Abstract
We appreciate Philips and colleagues' interest in our report on the associations between liver injury markers and coronavirus 2019 (COVID-19) mortality.(1) They raised the question regarding the application of liver injury markers. However, several of their interpretations of our results are misleading or incorrect. We understand that use of aspartate aminotransferase (AST) in isolation cannot comprehensively characterize liver injury.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.